UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
10151
DELISTED
Celularity Inc
CELUW
| $21 | ﹤0.01% |
5,278
+3,063
| +138% | +$21 |
2025 Q3
3 quarters
|
|
10152
SaverOne 2014 Ltd Warrant
SVREW
$47K
| $21 | ﹤0.01% |
1,952
+100
| +5% | +$1 |
2024 Q1
9 quarters
|
|
|
SMTK
10153
SmartKem
SMTK
$300K
| $21 | ﹤0.01% |
+2
| New | +$30 |
2026 Q2
0 quarters
|
|
10154
Stellar V Capital Corp Unit
SVCCU
| $21 | ﹤0.01% |
+2
| New | +$21 |
2026 Q2
0 quarters
|
|
10155
Alpha Brands Consumption Leaders ETF
LOGO
$32.9M
| $21 | ﹤0.01% |
1
-113
| -99% | -$2.31K |
2025 Q3
3 quarters
|
|
10156
Scilex Holding Co Warrant
SCLXW
$559K
| $20 | ﹤0.01% |
+155
| New | +$23 |
2026 Q2
0 quarters
|
|
10157
60 Degrees Pharmaceuticals Warrant
SXTPW
$37.6K
| $20 | ﹤0.01% |
647
-55
| -8% | -$3 |
2025 Q2
4 quarters
|
|
10158
Carbon Collective Short Duration Green Bond ETF
CCSB
$27.8M
| $20 | ﹤0.01% |
+1
| New | +$20 |
2026 Q2
0 quarters
|
|
10159
Columbia Short Duration High Yield ETF
HYSD
$106M
| $20 | ﹤0.01% |
+1
| New | +$20 |
2026 Q2
0 quarters
|
|
10160
Chicago Atlantic BDC
LIEN
$209M
| $20 | ﹤0.01% |
2
-63
| -97% | -$608 |
2025 Q2
4 quarters
|
|
10161
VivoSim Labs
VIVS
$2M
| $20 | ﹤0.01% |
18
-934
| -98% | -$1.26K |
2014 Q4
46 quarters
|
|
10162
Drugs Made In America Acquisition II Corp Right
DMIIR
| $20 | ﹤0.01% |
251
| – | – |
2026 Q1
1 quarter
|
|
10163
Leapfrog Acquisition Corp Units
LFACU
| $20 | ﹤0.01% |
+2
| New | +$20 |
2026 Q2
0 quarters
|
|
10164
Cyber Hornet S&P 500 and Ethereum 75/25 Strategy ETF
EEE
$551K
| $20 | ﹤0.01% |
+1
| New | +$20 |
2026 Q2
0 quarters
|
|
10165
Averin Capital Acquisition Corp
ACAA
$359M
| $20 | ﹤0.01% |
+2
| New | +$20 |
2026 Q2
0 quarters
|
|
10166
Abony Acquisition Corp I
AACO
$314M
| $20 | ﹤0.01% |
+2
| New | +$20 |
2026 Q2
0 quarters
|
|
10167
Eltek
ELTK
$43.7M
| $19 | ﹤0.01% |
2
-19
| -90% | -$166 |
2021 Q4
18 quarters
|
|
10168
DELISTED
Joby Aviation Warrants
JOBY.WS
| $19 | ﹤0.01% |
52
-1,825
| -97% | -$1.65K |
2022 Q2
16 quarters
|
|
10169
SIM Acquisition Corp I Warrant
SIMAW
| $19 | ﹤0.01% |
75
+30
| +67% | +$6 |
2024 Q3
7 quarters
|
|
10170
Amplify Travel Tech ETF
AWAY
$24.6M
| $18 | ﹤0.01% |
1
-600
| -100% | -$10.4K |
2021 Q4
18 quarters
|
|
10171
DELISTED
Dermata Therapeutics Warrant
DRMAW
| $18 | ﹤0.01% |
1,804
+500
| +38% | +$7 |
2026 Q1
1 quarter
|
|
10172
MicroSectors Energy -3x Inverse Leveraged ETNs
WTID
$416K
| $18 | ﹤0.01% |
3
+2
| +200% | +$10 |
2023 Q2
12 quarters
|
|
10173
Nexpu Ltd. Class A Ordinary Shares
DPU
$3.89M
| $18 | ﹤0.01% |
9
-230
| -96% | -$478 |
2025 Q4
2 quarters
|
|
|
XBNB
10174
DELISTED
Teucrium xETFs 2x Long Daily BNB ETF
XBNB
| $18 | ﹤0.01% |
+1
| New | +$24 |
2026 Q2
0 quarters
|
|
|
CHGA
10175
Change Agents Corp
CHGA
$997K
| $17 | ﹤0.01% |
3
-274
| -99% | -$2.12K |
2023 Q3
11 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.